Introduction
Neuron-specific enolase (NSE), also known as Enolase-2, is a glycolytic isoenzyme primarily found in central and peripheral neurons and neuroendocrine cells. NSE is released into the cerebrospinal fluid (CSF) upon neural tissue injury. Additionally, neoplasms originating from neural or neuroendocrine tissue release NSE into the bloodstream. NSE serves as a valuable biomarker and has been detected in patients with various tumors, including neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma. ENO2 is one of the three enolase isoenzymes present in mammals. The ENO2 isoenzyme is specifically found in mature neurons and cells of neuronal origin. During development in rats and primates, a transition from alpha enolase to gamma enolase (NSE) occurs in neural tissue.
Description
Human Neuron Specific Enolase (NSE) is a protein with a molecular mass of 45 kDa, produced in the human central nervous system (CNS).
Physical Appearance
Clear solution that has been sterilized by filtration.
Formulation
The protein is dissolved in a solution of 10mM NaH2PO4 buffer at pH 7.4, containing 150mM NaCl and 5mM MgSO4.
Stability
While Human NSE remains stable at 4°C for up to 1 week, it is recommended to store the protein at -18°C for long-term storage.
Purity
The purity of the Human NSE protein is greater than 96.0%.
Synonyms
Gamma-enolase, EC 4.2.1.11, 2-phospho-D-glycerate hydro-lyase, Neural enolase, Neuron-specific enolase, NSE, Enolase 2, ENO2.